
Organization · Angel Group
Golden Angels Investors
Golden Angels Investors is an angel investment group based in Brookfield, Wisconsin, founded in 2002. They focus on supporting Midwest entrepreneurs through seed and early-stage funding across various sectors.
Overview
What Golden Angels Investors does
What Golden Angels Investors is
Golden Angels Investors is an angel investment group based in Brookfield, Wisconsin, founded in 2002. They focus on supporting Midwest entrepreneurs through seed and early-stage funding across various sectors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Angel Group
- Founded
- Founded in 2002
- Approximate age
- About 24 years
- Structured capabilities
- Funder
- Last reviewed
- March 19, 2026
Official channels
Find Golden Angels Investors elsewhere
Open the official website or a supported primary organization account.
Capability profile
Golden Angels Investors as a funder
Investment thesis
Golden Angels Investors focuses on capital formation for entrepreneurs in the Midwest, leveraging the expertise of its members to assist in building companies.
Focus narrative
Golden Angels Investors invests across a wide range of industries, including healthtech, edtech, and B2B services. The organization leads investment opportunities and also participates in deals led by other investors. Members engage in sourcing deals and providing expertise during the diligence process, enhancing the evaluation of opportunities.
Focus and fit
- Stages
- Angel
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 10
Portfolio context
Notable portfolio companies include: Acorai: Develops a handheld and portable intracardiac pressure monitoring device for heart failure patients. DOCK Technologies: Provides a platform for quick time data collection at the patient's side. EmOpti: Offers software and hardware solutions for remote care network management. Immuto Scientific: Focuses on accelerating drug development through novel epitope mapping technology. LightLine Medical: Works on solutions to prevent and treat catheter-associated infections. PhoenixAid: Develops advanced diabetic foot ulcer dressings for underserved markets. Promentis Pharmaceuticals, Inc.: Innovates therapies for neuropsychiatric disorders. Rivermark Medical: Creates minimally-invasive treatments for benign prostatic hyperplasia. Tundra Targeted Therapeutics: Utilizes bispecific antibody technology to harness the immune system against cancer. Vital Sensors, Inc.: Develops an implantable intra-cardiac pressure device for heart failure management.
Connected ecosystem
Continue from Golden Angels Investors
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about Golden Angels Investors
Upseed classifies Golden Angels Investors under the Angel Group organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 19, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.